Skip to main content
. Author manuscript; available in PMC: 2012 Nov 20.
Published in final edited form as: Sci Transl Med. 2011 Aug 17;3(96):96ra77. doi: 10.1126/scitranslmed.3001318

Figure 2.

Figure 2

Heatmap of drug-disease scores. Most of the heatmap is white, indicating the majority of drug and gene expression profiles are not significantly concordant. Yellow indicates a negative (therapeutic) drug-disease score meaning the expression profiles of the two are opposing, and that the drug might be a potential treatment option of the disease. Blue indicates a positive drug-disease score meaning the expression profiles of the two are similar, and therefore the drug may be antagonistic towards the disease.